385.48MMarket Cap-9163P/E (TTM)
27.680High24.600Low448.22KVolume27.140Open26.870Pre Close11.58MTurnover6.77%Turnover RatioLossP/E (Static)14.85MShares74.49052wk High2.81P/B171.93MFloat Cap12.49052wk Low--Dividend TTM6.63MShs Float1115.000Historical High--Div YieldTTM11.46%Amplitude7.500Historical Low25.836Avg Price1Lot Size
Neurogene Stock Forum
This Will continue to drive downward. And after you finally sell your position for a loss, they will buy back. Follow the money
📊⚡️📊
NEWS
Neurogene Announces Upcoming Presentation of Safety Data from Phase 1/2 Trial of NGN-401 Gene Therapy for Rett Syndrome at ASGCT Meeting
NEW YORK--(BUSINESS WIRE)-- Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced that initial safety and tolerability data from its ongoing Phase 1/2 gene therapy clinical trial for Rett syndrome will be ...
No comment yet